Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Inhibition of natural antibody production by a combination of 15-deoxyspergualin, mizoribine, cyclophosphamide, and splenectomy.

Inhibition of natural antibody production by a combination of 15-deoxyspergualin, mizoribine, cyclophosphamide, and splenectomy. Transplant Proc. 1992 Apr; 24(2):687.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.